Skip to main content
. Author manuscript; available in PMC: 2013 Apr 23.
Published in final edited form as: Breast Cancer Res Treat. 2013 Mar 31;138(3):931–939. doi: 10.1007/s10549-013-2499-9

Table 4b.

Reasons for Premature Discontinuation of Endocrine Therapy (n=112)

Discontinued
n (%)
Patient Factors
Side Effects 45 (40.2)
Worried about risks 28 (25.0)
Dislike medication 26 (23.2)
I wasn’t sure if it was helping 25 (22.3)
Too expensive 21 (18.8)
I’d taken it long enough 20 (17.9)
I wanted to move on from cancer 14 (16.1)
I stopped for insurance reasons 8 (7.1)
Clinician Factors
Doctor told me to stop 28 (25.0)
Completed course of treatment 14 (12.5)

Note. Percentages do not add up to 100% as participants could choose multiple responses.